And the relative expression levels of Shh, Smo, and Gli1 mRNA in CML group were significantly higher than those in normal control group, suggesting that activation of the Hh pathway is quite common in CML. The gene discussed is SMO; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.